Breaking Research News

FDA Approves Larotrectinib

FDA Approves Larotrectinib for Advanced Cancers that Expresses TRK Precision medicine took the spotlight again last week as the Federal Drug Administration (FDA) approved the drug larotrectinib (Vitrakvi(r)) developed by Bayer and Loxo Oncology. According to the FDA, larotrectinib is approved for adults (pill form)…

Read Full Post

Research Interview Series Vlog

With the holidays amongst us, it’s a great time to discuss all things family health history. While you’re sitting around the table gobbling down turkey, or snuggling by the fire wrapping presents, it’s important to understand your family history, and if you may be at…

Read Full Post

Looking for Support and Resources? Look No Further!

Are you looking for real-time support and help finding local resources? Check out Fight CRC’s partnership with the Cancer Support Community. In 2015, Fight Colorectal Cancer (Fight CRC) and the Cancer Support Community (CSC) embarked on an important partnership to help patients and caregivers access…

Read Full Post

Cancer, Pneumonia and Flu, and You

With fall just around the corner, the Centers for Disease Control (CDC) expects flu season to begin ramping up within the next few months. According to the CDC, the flu season often times begins increasing around October with peak flu season occurring notoriously between December…

Read Full Post

Loss of the “Old Normal”

Accepting the changes in your life after a colon or rectal cancer diagnosis can be difficult. Many people who are able to process losses and adjust to a “new normal” report high levels of life satisfaction, good quality of life and overall happiness. There are…

Read Full Post

The Young Colorectal Cancer Caregiver

Being a caregiver is not easy. While caregivers often face physical and emotional challenges, being a caregiver is an experience that ebbs and flows — there’s the bad stuff and sometimes there’s good stuff, too. Becoming a caregiver requires adjustment, like many transitional times in…

Read Full Post
Breaking Research News

Reducing the Burden of Polyps in FAP Patients

Patients with familial adenomatous polyposis (FAP) are at a markedly increased risk for colorectal polyps and cancer. In fact, the risk of developing CRC is nearly 100% if FAP goes untreated and unmanaged. Therefore, there are multiple, critical management issues during the entire course of…

Read Full Post